Читать книгу Cukrzyca. Personalizacja terapii i opieki nad pacjentem - Группа авторов - Страница 14
Część I
WYBRANE ZAGADNIENIA
z diabetologii, pediatrii i psychologii klinicznej
3
Dynamika progresji cukrzycy typu 1 od jej rozpoznania. Monitorowanie sekrecji C-peptydu
Piśmiennictwo
Оглавление1. Davis A.K., DuBose S.N., Haller M.J. i wsp.: Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes. Diabetes Care 2015, 38(3): 476–481.
2. DiMeglio L.A., Cheng P., Beck R.W. i wsp.: Changes in beta cell function during the proximate post-diagnosis period in persons with type 1 diabetes. Pediatr. Diabetes 2016, 17(4): 237–243.
3. Forst T., Kunt T., Pfützner A. i wsp.: New aspects on biological activity of C-peptide in IDDM patients. Exp. Clin. Endocrinol. Diabetes 1998, 106(4): 270–276.
4. Hao W., Gitelman S., DiMeglio L.A. i wsp.: Fall in C-peptide during first 4 years from diagnosis of type 1 diabetes: Variable relation to age, HbA1c, and insulin dose. Diabetes Care 2016, 39(10): 1664–1670.
5. Hope S.V., Knight B.A., Shields B.M. i wsp.: Random non-fasting C-peptide: Bringing robust assessment of endogenous insulin secretion to the clinic. Diabet. Med. 2016, 33(11): 1554–1558.
6. Hope S.V., Wienand-Barnett S., Shepherd M. i wsp.: Practical Classification Guidelines for Diabetes in patients treated with insulin: A cross-sectional study of the accuracy of diabetes diagnosis. Br. J. Gen. Pract. 2016, 66(646): 315–322.
7. Steele C., Hagopian W.A., Gitelman S. i wsp.: Insulin secretion in type 1 diabetes. Diabetes 2004, 53(2): 426–433.
8. Watkins R.A., Evans-Molina C., Blum J.S. i wsp.: Established and emerging biomarkers for the prediction of type 1 diabetes: A systematic review. Transl. Res. 2014, 164(2): 110–121.
9. Weets I., Kaufman L., Van der Auwera B. i wsp.: Seasonality in clinical onset of type 1 diabetes in Belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8-negative males, which explains the male to female excess in incidence. Diabetologia 2004, 47(4): 614–621.
10. Yu L., Miao D., Scrimgeour L. i wsp.: Distinguishing persistent insulin autoantibodies with differential risk: Nonradioactive bivalent proinsulin/insulin autoantibody assay. Diabetes 2012, 61(1): 179–186.
